Bringing the Oncology Community Together

Dr. Powell on the Treatment of Older Patients With AML

Bayard L. Powell, MD
Published Online: Tuesday, August 20, 2013
Bayard L. Powell, MD, the Director-At-Large and a Professor in Hematology & Oncology at the Wake Forest Baptist Medical Center Comprehensive Cancer Center, discusses the treatment of older patients with acute myeloid leukemia (AML).

The oncology community is vying to determine which older patients can tolerate aggressive treatment for AML and which patients need new options. Among the group of those who need other treatments, some patients are not in good shape to start with and may need an earlier intervention.

In looking at interventions, Powell says, researchers are conducting activity or exercise studies. One study is looking at older patients with AML who are not very fit to start with and determining their tolerance to treatment following regular exercise. An upcoming study is looking at the impact of yoga, both psychologically and physically, on a patient's ability to tolerate treatment. Powell says he is excited to see where these studies lead and incorporate new strategies into treatment for this group of patients.

Related Articles
New MRD Assay Helps Move Testing Forward in Multiple Myeloma Research
An improved assay for assessing MRD status in patients with multiple myeloma is contributing to the momentum for using MRD as a surrogate endpoint for survival in clinical trials and as a tool with the potential to help guide therapy choices.
FDA Approves First-Line Ofatumumab for Fludarabine-Ineligble Patients With CLL
The FDA has approved ofatumumab plus chlorambucil for previously untreated patients with chronic lymphocytic leukemia who are considered inappropriate for treatment with fludarabine therapy.
Epizyme Maintains Independence, Advances HMT-Inhibitor Platform
Epizyme, a Cambridge, Massachusetts-based biotech, opted for independence, with a successful IPO in 2013.
Most Popular Right Now
More Reading
External Resources

American Journal of Managed Care
HCPLive
PainLive
Pharmacy Times
Physicians' Education Resource
Physician's Money Digest
Specialty Pharmacy Times
TargetedOnc
OncLive Resources

Archives
Blogs
OncLive TV
Oncology Nurses
Publications
Specialties
Web Exclusives


About Us
Advertise
Advisory Board
Contact Us
Forgot Password
Privacy Policy
Terms & Conditions
Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747

Copyright OncLive 2006-2014
Intellisphere, LLC. All Rights Reserved.